AMRX Stock Overview – The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
NYSE:AMRX

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 2, 2024

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$AMRX N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
Amneal Pharmaceuticals, Inc. Loading... Loading...
Sector Name Loading... N/A

Related

ALKSAlkermes plc-2.4%
NBIXNeurocrine Biosciences, Inc.-3.3%
ITCIIntra-Cellular Therapies, Inc.9.6%
DCPHDeciphera Pharmaceuticals, Inc.0.0%
DVAXDynavax Technologies Corporation-0.5%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue786M866M1,018M1,034M1,663M1,626M1,993M2,094M2,212M2,394M
Growth Rate-10.3%17.5%1.5%60.9%-2.2%22.5%5.1%5.7%8.2%
EBITDA243M253M306M271M416M70M349M443M447M418M
EBITDA Margin31.0%29.2%30.1%26.2%25.0%4.3%17.5%21.1%20.2%17.5%
Net Income177M169M207M168M-170M-604M69M20M-255M-84M
NI Margin22.5%19.6%20.4%16.2%-10.2%-37.1%3.4%1.0%-11.5%-3.5%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.